Curative Secures $150M in Series B Funding, Achieves Unicorn Status

Technology-enabled health plan provider Curative has successfully raised $150 million in a Series B funding round, propelling the company to a valuation of $1.275 billion. This significant investment underscores growing interest in Curative's innovative health insurance model, which offers plans with zero out-of-pocket costs for members.

Groundbreaking Health Plan Model

Curative's unique approach to health insurance has garnered attention from investors and industry experts alike. The company's plans eliminate copayments, deductibles, and coinsurance for members who complete an annual preventive care visit, known as the Baseline Visit. This model has reportedly led to impressive results:

• 20% increase in primary care engagement
• 30% decrease in hospitalizations
• Up to 40% lower drug costs

Fred Turner, CEO and co-founder of Curative, emphasized the company's mission: "We're accelerating the modernization of the member experience, expanding into new markets and scaling the impact we know the industry desperately needs."

Investment Details and Future Plans

The Series B round was led by TED Chairman Chris Anderson's Upside Vision Fund, with significant contributions from Justin Mateen, founder of JAM Fund. Other notable investors included Mike Novogratz of Galaxy Digital, Stanley Druckenmiller's Duquesne Family Office, DCVC, and Martin Varsavsky.

Curative plans to utilize the new funding for:

1. National expansion, with a focus on the Mid-Atlantic region
2. Bolstering reserves to meet regulatory requirements
3. Enhancing member engagement initiatives
4. Developing AI capabilities
5. Expanding its provider network

Currently operating in Texas, Florida, and Georgia, Curative has grown rapidly since its launch less than three years ago. The company now serves over 1,200 employer clients and covers more than 165,000 members.

Industry Impact and Outlook

Chris Anderson, whose fund led the investment round, praised Curative's progress: "The healthcare industry is notoriously challenging with so many misaligned incentives. To see Curative successfully setting a new standard for employer-based health insurance that actually makes people healthier—wow, that has been exhilarating."

As Curative continues to disrupt the traditional health insurance model, industry observers are taking note. Fred Turner commented on the broader implications: "For years, industry watchers and employers have talked about an inflection point where lack of innovation, rising frustration, and runaway healthcare costs would collide. Curative is leading that change moment."